Effects of Blue of Glasses VS Standard Lenses on Contrast Sensitivity & Visual Fatigue in Myopic & Non-Myopic Adults

December 13, 2024 updated by: Muhammad Naveed Babur, Superior University

The Effects of Blue of Blue Light-blocking Glasses Versus Standard Lenses on Contrast Sensitivity & Visual Fatigue in Myopic & Non-Myopic Adults

This study investigates the effects of blue light-blocking glasses compared to standard lenses on contrast sensitivity and visual fatigue in myopic and non-myopic adults. With the growing use of digital screens, blue light exposure has raised concerns due to potential eye strain, sleep disruption, and visual fatigue.

Study Overview

Detailed Description

While blue light-blocking lenses are marketed to address these issues, evidence of their efficacy, particularly for different refractive errors like myopia, remains inconclusive. Using a randomized controlled design, this study will assess both groups across specific visual tasks to measure contrast sensitivity and visual fatigue. Outcomes are evaluated using validated tools, including the Computer Vision Syndrome Questionnaire (CVS-Q) and Visual Fatigue Questionnaire (VFQ), with measurements taken at baseline, 2 weeks, and 4 weeks. Findings are expected to clarify the potential advantages of blue light-blocking glasses over standard lenses, aiding in evidence-based recommendations for adults with varying visual needs.

Study Type

Interventional

Enrollment (Actual)

64

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Punjab
      • Taunsa, Punjab, Pakistan
        • Tehsil Headquarters (THQ)

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Adults aged 18-50 years.
  • Both myopic (with any degree of myopia) and non-myopic adults.
  • Participants who use computer screens for at least four hours per day.
  • Individuals currently using corrective lenses or willing to wear study-provided glasses during the experiment.
  • Individuals willing to complete the study protocol, which includes attending follow-up examinations and filling out visual fatigue questionnaires.

Exclusion Criteria:

  • A history of any serious vision-related condition (such as glaucoma, cataracts, or retinal problems).
  • Individuals who have already undergone refractive surgery (e.g., LASIK) or other types of eye surgery.
  • Systemic conditions affecting vision include diabetes, neurological problems, and any other ailment that may impair visual ability.
  • Taking drugs that are known to impair vision or produce visual tiredness (for example, certain antihistamines and antidepressants).
  • Pregnant women's visual performance may be affected by hormonal changes.
  • People with uncorrected vision difficulties cannot use the prescription lenses during study time.
  • Participants who are allergic or sensitive to lens materials.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Control Group
Participants in this arm wore standard lenses without any blue light-blocking properties. These lenses allow the full spectrum of visible light to pass through and serve as a baseline control to measure against the blue light-blocking glasses. Participants used these lenses under the same conditions to assess contrast sensitivity and visual fatigue without blue light filtration.
Experimental: interventional group
Participants in this arm wore blue light-blocking glasses designed to filter out a portion of short-wavelength blue light. These lenses were intended to reduce eye strain and protect against blue light exposure, especially during prolonged screen time. Participants used blue light-blocking glasses consistently throughout the study period to assess their effect on contrast sensitivity and visual fatigue.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Contrast Sensitivity
Time Frame: 12 Months
Measured using the Pelli-Robson chart to assess changes in visual acuity and sensitivity to contrast under different lens conditions.
12 Months
Visual Fatigue
Time Frame: 12 months

The Visual Fatigue Questionnaire (VFQ) was assessed to evaluate subjective experiences of eye strain and fatigue during visual tasks.

Computer Vision Syndrome: Evaluated with the Computer Vision Syndrome Questionnaire (CVS-Q) to quantify symptoms associated with prolonged screen use, including dryness, discomfort, and eye strain."

12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 28, 2024

Primary Completion (Actual)

August 1, 2024

Study Completion (Estimated)

January 31, 2025

Study Registration Dates

First Submitted

December 13, 2024

First Submitted That Met QC Criteria

December 13, 2024

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

December 13, 2024

Last Verified

December 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • MSRSW/Batch-Fall22/749

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe